Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis
暂无分享,去创建一个
Mark G. Jones | A. Nicholson | D. Hansell | D. Davies | I. Sinclair | K. Brown | L. Richeldi | A. Fabre | Philipp Schneider | F. Cinetto | G. Sgalla | M. Mavrogordato | S. Jogai | A. Alzetani | B. Marshall | K. O'Reilly | J. Warner | P. Lackie
[1] H. Russell. A modification of Movat's pentachrome stain. , 1972, Archives of pathology.
[2] Russell Hk,et al. A modification of Movat's pentachrome stain. , 1972 .
[3] L. Feldkamp,et al. Practical cone-beam algorithm , 1984 .
[4] J. Myers,et al. Bronchiolitis Obliterans and Usual Interstitial Pneumonia: A Comparative Clinicopathologic Study , 1986, The American journal of surgical pathology.
[5] H. J. G. Gundersen,et al. The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[6] J. Nyengaard,et al. The number of glomerular capillaries estimated by an unbiased and efficient stereological method , 1993, Journal of microscopy.
[7] J R Nyengaard,et al. The Conneulor: unbiased estimation of connectivity using physical disectors under projection. , 1993, Bone.
[8] K P Whittall,et al. Quantification of idiopathic pulmonary fibrosis using computed tomography and histology. , 1997, American journal of respiratory and critical care medicine.
[9] J. Myers,et al. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.
[10] S. Iyer,et al. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. , 1999, The Journal of pharmacology and experimental therapeutics.
[11] M J Paulus,et al. High resolution X-ray computed tomography: an emerging tool for small animal cancer research. , 2000, Neoplasia.
[12] W. Thurlbeck,et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. , 2001, American journal of respiratory and critical care medicine.
[13] A. Nicholson,et al. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.
[14] F. Martinez,et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. , 2003, American journal of respiratory and critical care medicine.
[15] T. Rogers. Fibroblastic foci in usual interstitial pneumonia. , 2004, American journal of respiratory and critical care medicine.
[16] Matthias Ochs,et al. The number of alveoli in the human lung. , 2004, American journal of respiratory and critical care medicine.
[17] Dianna D Cody,et al. Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography. , 2006, Academic radiology.
[18] K. Brown,et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. , 2006, American journal of respiratory and critical care medicine.
[19] G Allan Johnson,et al. A MICRO–COMPUTED TOMOGRAPHY–BASED METHOD FOR THE MEASUREMENT OF PULMONARY COMPLIANCE IN HEALTHY AND BLEOMYCIN–EXPOSED MICE , 2007, Experimental lung research.
[20] T. Farncombe,et al. Journal of Translational Medicine Comparison between Conventional and "clinical" Assessment of Experimental Lung Fibrosis , 2008 .
[21] E. B. Meltzer,et al. Idiopathic pulmonary fibrosis , 2008, Orphanet journal of rare diseases.
[22] T. Hartman,et al. Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. , 2008, Respiratory medicine.
[23] B. Metscher. MicroCT for developmental biology: A versatile tool for high‐contrast 3D imaging at histological resolutions , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.
[24] H. Gundersen,et al. Stereological estimation of the total number of ventilatory units in mice lungs , 2010, Journal of microscopy.
[25] G. Raghu,et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology , 2010, European Respiratory Journal.
[26] Jürgen Borlak,et al. Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-β1 , 2010, Respiratory research.
[27] Stephan Saalfeld,et al. As-rigid-as-possible mosaicking and serial section registration of large ssTEM datasets , 2010, Bioinform..
[28] T. Rodt,et al. Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-b 1 , 2011 .
[29] Warren B. Gefter,et al. The n e w e n g l a n d j o u r n a l of m e d i c i n e , 2011 .
[30] C. Barkauskas,et al. Pulmonary fibrosis: patterns and perpetrators. , 2012, The Journal of clinical investigation.
[31] K. Leslie. Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. , 2012, Archives of pathology & laboratory medicine.
[32] M. L. R. D. Christenson,et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management , 2012 .
[33] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[34] Uwe Himmelreich,et al. Quantification of Lung Fibrosis and Emphysema in Mice Using Automated Micro-Computed Tomography , 2012, PloS one.
[35] Robert Alexander,et al. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation , 2013, European Respiratory Journal.
[36] H. Iwasaki,et al. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non‐specific interstitial pneumonia , 2013, Respirology.
[37] R. Sussman,et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.
[38] B. Ryffel,et al. Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[39] G. Verleden,et al. The site and nature of airway obstruction after lung transplantation. , 2014, American journal of respiratory and critical care medicine.
[40] C. Vancheri,et al. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[41] A. Azuma,et al. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .
[42] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.
[43] J. Hogg,et al. Three Dimensional Imaging of Paraffin Embedded Human Lung Tissue Samples by Micro-Computed Tomography , 2015, PloS one.
[44] V. Thannickal,et al. Novel Mechanisms for the Antifibrotic Action of Nintedanib. , 2016, American journal of respiratory cell and molecular biology.